Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Diabetes Pen Market Through 2034?
In the past few years, the diabetes pen market has significantly expanded. It is predicted that its value will increase from $29.24 billion in 2024 to $31.04 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historic period is predominantly due to the effective management of limited water resources, the aging water infrastructure, an increased demand for high-quality water services, a growing need for smart water solutions, and the improvement of operational efficiency.
Expectations are high for significant expansion in the diabetes pen market, anticipated to reach a valuation of $39.59 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.3%. This growth projection over the forecast period can be linked to an increasing population and urbanization, intensifying water pollution and contamination, the need for more efficient resource management, enhanced accuracy and immediacy in water data, and growing demand for water reuse and recycling. The forecast period will also witness continued advancements in digital technology like artificial intelligence (AI) and machine learning (ML), greater adoption of internet of things (IoT) and cloud computing, a necessity to resolve water-related problems, increased investment in water infrastructure, and the increased digitalization of the utility sector.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13639&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Diabetes Pen Market?
The global surge in diabetes is anticipated to boost the expansion of the diabetes pen market. Diabetes encompasses a range of persistent metabolic disorders marked by high blood sugar levels, also known as hyperglycemia. Diabetes pens, a form of insulin delivery gadget, allow for precise dosage, better compliance, and lower risk of hypoglycemia. These pens cause less pain at the injection site and are favored by individuals with diabetes who need insulin. For example, data from the American Diabetes Association in May 2023 revealed that in 2021, the age-adjusted prevalence of Impaired Glucose Tolerance (IGT) in adults aged 20-79 years globally was 9.1% (464 million). This number is predicted to rise to 10.0% (638 million) by 2045. Consequently, the rising global prevalence of diabetes is stimulating the advancement of the diabetes pen market.
Which Key Market Segments Comprise the Diabetes Pen Market and Drive Its Revenue Growth?
The diabetes penmarket covered in this report is segmented –
1) By Product: Insulin Pens; Pen Needles
2) By Usage: Reusable Injection Pens; Disposable Injection Pens
3) By Therapy: Insulin; Glucagon-like Peptide-1; Growth Hormones; Fertility; Osteoporosis
4) By Distribution Channel: Retail Pharmacies; Online Medical Stores; Diabetes Clinics
Subsegments:
1) By Insulin Pens: Pre-Filled Insulin Pens; Disposable Insulin Pens; Reusable Insulin Pens
2) By Pen Needles: Standard Pen Needles; Safety Pen Needles; Specialty Pen Needles
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13639&type=smp
Which Areas Are Leading Regions in the Diabetes Pen Market Expansion Across the Globe?
North America was the largest region in the diabetes pen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes pen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theDiabetes Pen Market Over the Coming Years?
Major firms in the diabetes pen market are concentrating on creating innovative products, such as virtually pain-free injections, to improve the user’s experience. A virtually painless injection is a method of administering medication that aims to reduce discomfort. It is designed to increase patient comfort, making it easier for people to handle their insulin administration without fear or discomfort. For instance, in May 2022, Roche AG, a medical equipment company based in Switzerland, introduced ACCU-FINE pen needles. These are designed to improve the insulin administration experience for users. They aim to offer a virtually painless injection while also improving compliance and health outcomes for those living with diabetes.
View the full report here:
https://www.thebusinessresearchcompany.com/report/diabetes-pen-global-market-report
How Is the Diabetes Pen Market Conceptually Defined?
A diabetes pen refers to a medical device designed to administer insulin to individuals with diabetes. It is an alternative to traditional insulin delivery methods such as vial and syringe. The diabetes pen is a convenient and user-friendly tool that allows people with diabetes to self-administer insulin in a more discreet and portable manner.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13639
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model